2 results

• Hintermann Ankle Replacement Problems Draw New FDA Warning Over ‘Higher-Than-Expected’ Failure Rates

  June 11, 2026

  Michael Adams

  Federal regulators are advising surgeons and patients to consider alternatives to the Hintermann H3 Total Ankle Replacement system after post-approval data showed failure rates far exceeding those reported during premarket testing.

• Hintermann H3 Ankle Replacement Failures Occur in 31.8% of Patients at 10 Years, FDA Warns

  November 4, 2025

  Michael Adams

  New post-market data reveals that Hintermann H3 ankle replacements are failing at rates more than 15 percentage points higher than first reported, according to findings released after federal regulators issued a safety warning early last year.